What is the market capitalization of RenovoRx, Inc.?

RenovoRx, Inc. (RNXT) has a market capitalization of approximately 40,841,775 USD.

Where can I buy RNXT in Canada?

RNXT can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

RNXT

RenovoRx, Inc.

RenovoRx, Inc. (RNXT) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 41 million USD (micro-cap).

Details

Price0.91 USD

Market cap40.84 M USD

Payout ratio0.00%

ROE-100.48%

Debt / Equity0.69%

SectorHealthcare

Websiterenovorx.com

Updated a few minutes ago

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.